Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anu Kurve"'
Autor:
Manfred Danilovits, Anu Kurve, Charles D. Wells, Tiina Kummik, Klavdia Levina, Davide Manissero, Lawrence Geiter, Lea Pehme, Tarmo Tomson, Vaira Leimane, Girts Skenders, Andra Cirule, Vija Skripconoka
Publikováno v:
The European Respiratory Journal
Multidrug-resistant and extensively drug-resistant tuberculosis (TB) are associated with worse treatment outcomes for patients, including higher mortality, than for drug-sensitive tuberculosis. Delamanid (OPC-67683) is a novel anti-TB medication with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d62247d67572a53df62d6f8e514c226
https://doi.org/10.1183/09031936.00125812
https://doi.org/10.1183/09031936.00125812
Autor:
Dante E. Vargas-Vasquez, Won-Jung Koh, Barbara J. Seaworth, Maria Tarcela Gler, Epifanio Sanchez-Garavito, Thelma E. Tupasi, Hideo Ogata, Heping Xiao, Joon Chang, Vija Skripconoka, Tae Sun Shim, Anu Kurve, Jose L. Cabrera-Rivero, Mohamed A. Awad, Katsuhiro Suzuki, Gee Young Suh, Seung Kyu Park, Lawrence Geiter, Charles D. Wells, Manfred Danilovits, Mengqiu Gao
Publikováno v:
The New England journal of medicine. 366(23)
Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f542714a8f39fc32e5236199e173a28
https://pubmed.ncbi.nlm.nih.gov/23289099
https://pubmed.ncbi.nlm.nih.gov/23289099